← Open Payments lookup

ANA GONZALEZ VILLASENOR: Open Payments

NPI 1518573492 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,078 in 105 payments from 20 companies in 2025. Trend: 2023 $1,537 · 2024 $2,007 · 2025 $2,078

Food & beverage: $2,078
CompanyPaymentsAmount
ABBVIE INC.19$327
Novo Nordisk Inc11$228
Amgen Inc.14$209
AstraZeneca Pharmaceuticals LP9$192
Salix Pharmaceuticals, a division of Bausch Health US, LLC11$185
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$137
Regeneron Healthcare Solutions, Inc.5$132
GENZYME CORPORATION4$113
Boehringer Ingelheim Pharmaceuticals, Inc.4$81
Sumitomo Pharma America, Inc.3$70

Products named: DUPIXENT, QULIPTA, XIFAXAN, OTEZLA, CAPLYTA, BREZTRI, Ozempic, Rybelsus.

Industry payments across NY — which companies pay providers there.